Follicular carcinoma of thyroid following successful liver transplantation--a report.
Follicular carcinoma of the thyroid is a relatively rare malignancy in childhood even in paediatric solid organ transplant recipients. The risk of developing de novo malignancies after liver transplantation is higher compared to the general population. We report an 18-yr-old girl who had successfully undergone liver transplantation five yr earlier for neonatal sclerosing cholangitis complicated by the development of dysplastic nodules. Baseline immunosuppression was with tacrolimus and prednisolone. Mycophenolate mofetil was later added in view of steroid-resistant episodes of graft rejection. She subsequently suffered from marked obesity and essential hypertension needing antihypertensive medication. Five yr after liver transplantation, she presented with a right-sided thyroid swelling that was rapidly progressive with no associated lymphadenopathy and normal systemic examination. Ultrasound of her neck revealed a solid lesion in the right lobe of the thyroid gland with ill-defined margins, and a diagnostic right thyroid lobectomy confirmed the diagnosis of follicular carcinoma with focal capsular and vascular invasion. She underwent total thyroidectomy and currently remains well on thyroxine supplements. Our report highlights the need for high level of suspicion and prompt investigation into any abnormal lesion in the long-term follow-up of solid organ transplant recipients.
Children's Liver Unit, Leeds General Infirmary, Leeds, UK.
Sri
S
Dantuluri
Arun
A
Urs
Sivaramakrishnan Venkatesh
SV
Karthik
D018263:Adenocarcinoma, Follicular / Q000150:complications* / Q000175:diagnosis; D000293:Adolescent; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000628:therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D016031:Liver Transplantation / Q000379:methods*; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D009765:Obesity / Q000150:complications; D011239:Prednisolone / Q000494:pharmacology; D016559:Tacrolimus / Q000494:pharmacology; D013964:Thyroid Neoplasms / Q000150:complications* / Q000175:diagnosis; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D011239:Prednisolone; D009173:Mycophenolic Acid; D016559:Tacrolimus